Thermo Fisher Scientific Inc.(TMO)

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Latest News & Analysis
Thermo Fisher Scientific Q2 2025 Earnings Beat: Financial Resilience and Strategic Growth Insights
Thermo Fisher Scientific's Q2 2025 earnings beat expectations with strong revenue growth and raised guidance, highlighting operational resilience and innovation leadership.
Thermo Fisher Scientific Inc. Q2 2025 Earnings Beat and Strategic Advances | Market Analysis
Thermo Fisher Scientific (TMO) surpasses Q2 2025 earnings expectations with $10.85B revenue, strategic growth in life sciences, leadership updates, and raised guidance.
Thermo Fisher Scientific Inc. Q2 2025 Analysis: Earnings Beat, Strategic Growth, and Market Position
Thermo Fisher Scientific's Q2 2025 earnings beat expectations, driven by biopharma expansion, strategic Sanofi partnership, and operational excellence.
Thermo Fisher Scientific (TMO) Q2 2025 Earnings Analysis and Strategic Insights
Explore Thermo Fisher Scientific's Q2 2025 earnings drivers, including Sanofi acquisition impact, segment growth, and financial performance analysis.
Thermo Fisher Scientific Inc. (TMO) Sanofi Acquisition Boosts U.S. Manufacturing and Earnings Amid Market Challenges
Thermo Fisher Scientific's strategic acquisition of Sanofi's Ridgefield site enhances U.S. manufacturing capacity, driving long-term earnings growth despite near-term headwinds.
Thermo Fisher Scientific Inc. Precision Oncology Growth and Financial Insights July 2025
Thermo Fisher's FDA-approved Oncomine Assay boosts precision oncology leadership, driving revenue growth and strengthening competitive positioning ahead of Q2 earnings.
Thermo Fisher Scientific (TMO) Market Update: Precision Oncology Leadership and Financial Insights
Explore Thermo Fisher Scientific's latest precision oncology breakthroughs, FDA approvals, and financial performance shaping its market leadership and growth prospects.
Thermo Fisher Scientific Inc. (TMO) Q2 2025 Earnings Analysis and Strategic Update
Comprehensive analysis of Thermo Fisher Scientific's Q2 2025 earnings, product innovations, strategic collaborations, and financial performance amid macroeconomic challenges.
Thermo Fisher Scientific Inc. (TMO) Deep Dive: Strategic Growth, Financial Resilience, and Market Positioning
Explore Thermo Fisher Scientific's latest strategic moves, financial performance, and market positioning as it advances diagnostics, cell therapy, and government contracts.
Thermo Fisher Scientific Inc. (TMO) Latest Corporate Developments and Financial Insights
In-depth analysis of Thermo Fisher Scientific's recent financial performance, FDA approval milestones, and strategic positioning in the life sciences sector.
Thermo Fisher Scientific (TMO): Strategic Diagnostics Sale & Growth Pivot
Thermo Fisher Scientific's potential $4 billion diagnostics sale aims to pivot towards high-growth sectors like cell therapy and mRNA, enhancing future profitability.
Thermo Fisher (TMO) Strategic Pivot: Diagnostics Divestment & Growth
Thermo Fisher (TMO) divests its diagnostics business for $4B, strategically pivoting to high-growth biopharma services and cell therapy. Analyze the impact on TMO's financials and future innovation.
Thermo Fisher Scientific's Strategic Diagnostics Sale: TMO's Growth Pivot
Thermo Fisher Scientific is reportedly exploring the sale of its diagnostics unit for $4 billion, a strategic move to sharpen its focus on high-growth Life Sciences and Analytical Instruments segments.
Thermo Fisher Scientific (TMO): Strategic Shifts & Biopharma Focus
Thermo Fisher Scientific's strategic moves, from accelerating drug development to a major diagnostics divestiture, are reshaping its biopharma focus.
Thermo Fisher Scientific (TMO): Strategic Shifts and Innovation Drive Growth
Thermo Fisher Scientific's strategic divestment of its diagnostics unit and groundbreaking biopharma innovations are reshaping its market position and long-term growth.
Thermo Fisher Scientific (TMO): Strategic Innovations & Market Outlook
Thermo Fisher Scientific redefines its strategic trajectory, launching cutting-edge mass spectrometers and divesting its diagnostics unit for $4 billion.
Thermo Fisher Scientific's Innovation Drives Biopharma, Valuation Insights
Thermo Fisher Scientific's latest mass spectrometer launches at ASMS 2025 promise to dramatically cut biopharma research timelines, signaling strategic innovation.
Thermo Fisher's Strategic Mass Spectrometer Launches: Analysis
Thermo Fisher's new mass spectrometers are poised to redefine biopharma research, signaling strategic strength amidst market shifts and reinforcing its leadership.
Thermo Fisher Scientific: New Analyzers, Oncology Focus, and Macro Headwinds
Thermo Fisher Scientific recently launched new narcotics analyzers and highlighted oncology advancements, navigating macroeconomic headwinds like tariffs and funding cuts.
Thermo Fisher Scientific: Krios 5 Cryo-TEM, Sustainability, and Market Impact
Thermo Fisher Scientific (TMO) innovates with Krios 5 Cryo-TEM, sustainable solutions, and semiconductor analysis, impacting market position and investor expectations.
Thermo Fisher Scientific (TMO): Growth, Acquisitions, and Market Impact
Thermo Fisher Scientific strategically navigates growth through innovation, acquisitions, and collaborations, bolstering its life sciences leadership despite 'weak guidance'.
Thermo Fisher Scientific: Vulcan Lab, Solventum Acquisition & Market Impact
Thermo Fisher Scientific expands with Vulcan Lab and Solventum acquisition, showcasing financial strength and shareholder commitment amidst sector challenges.
Thermo Fisher Scientific: Innovation, Acquisitions, and Market Impact
Thermo Fisher strategically advances in semiconductor analysis and biopharma. R&D, debt management, and clinical research expansion position TMO for sustained growth.
Thermo Fisher Scientific (TMO): Growth Strategy, Market Impact
Thermo Fisher Scientific (TMO) navigates growth through strategic acquisitions, innovation, and shareholder returns. Q4 and FY24 results exceed expectations.
Thermo Fisher Scientific: Intraday Strategic Snapshot
On March 5, 2025, Thermo Fisher Scientific Inc. demonstrates strategic acquisitions, robust financial performance, and steady intraday momentum.
Thermo Fisher Scientific: Acquisition, Clinical Registry, and Growth
Thermo Fisher Scientific is strategically expanding through acquisitions and clinical registries, positioning itself for continued growth. Read our analysis.
Thermo Fisher Scientific: Strategic Acquisition, Innovation, and Value
Thermo Fisher Scientific (TMO) is expanding through strategic acquisitions, innovation, and shareholder value initiatives, positioning it for future growth.
Thermo Fisher Scientific: Strategic Acquisitions, Innovation, and Market Expansion
Thermo Fisher Scientific expands capabilities via strategic acquisitions, innovation, and increased shareholder value. A deep dive into recent developments and market impacts.
Thermo Fisher Scientific: Acquisition, Growth, and Market Outlook
Thermo Fisher Scientific expands bioproduction with Solventum acquisition, CEO presents at TD Cowen, and capitalizes on molecular diagnostics growth trends.
Thermo Fisher Scientific: Developments and Market Trends in 2025
Thermo Fisher Scientific is navigating growth through strategic initiatives and market expansion, signaling a strong outlook for 2025 and beyond.
Thermo Fisher Scientific: Dividend, Director & Innovation Update
A dividend hike, board appointment, and product launches signal robust growth for Thermo Fisher Scientific.
Thermo Fisher Scientific Advances Diagnostics and Spatial Imaging Amidst Market Growth
Intraday update for Tuesday, February 18, 2025 on Thermo Fisher Scientific, highlighting new product launches, market growth forecasts and competitive insights.
Thermo Fisher Scientific: Driving Growth Through Innovation
This in-depth analysis details Thermo Fisher Scientific’s strong Q4 2024 results, product innovations, and strategic market expansion across key sectors.